Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines
Simultaneous administration of different vaccines is a strategy to increase the possibility to receive vaccines at appropriate age, safely and effectively, reducing the number of sessions and allowing a more acceptable integration of new vaccines into National Immunization Programs (NIPs). Co-admini...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-06-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2019.1688032 |
_version_ | 1827809615963750400 |
---|---|
author | Paolo Bonanni Sara Boccalini Angela Bechini Ornella Varone Giulio Matteo Federica Sandri Giovanni Gabutti |
author_facet | Paolo Bonanni Sara Boccalini Angela Bechini Ornella Varone Giulio Matteo Federica Sandri Giovanni Gabutti |
author_sort | Paolo Bonanni |
collection | DOAJ |
description | Simultaneous administration of different vaccines is a strategy to increase the possibility to receive vaccines at appropriate age, safely and effectively, reducing the number of sessions and allowing a more acceptable integration of new vaccines into National Immunization Programs (NIPs). Co-administration can be performed when there are specific indications in the Summary of Product Characteristics (SmPC) of the vaccines; but, in absence of these indications, the practice is possible if there are no specific contraindications nor scientific evidence to discourage simultaneous administration. The aim of this work is to review the safety and efficacy of co-administration of the tetravalent measles, mumps, rubella, and varicella (MMRV) and the meningococcal C (Men C) conjugate vaccines after 12 months of age. Several studies demonstrated that MMRV and Men C conjugate vaccines can be administered concomitantly without a negative impact on the safety and immunogenicity of either vaccines, inducing highly immunogenic responses. |
first_indexed | 2024-03-11T22:44:02Z |
format | Article |
id | doaj.art-b5aa70879ec84933a5de504c8c6e97a9 |
institution | Directory Open Access Journal |
issn | 2164-5515 2164-554X |
language | English |
last_indexed | 2024-03-11T22:44:02Z |
publishDate | 2020-06-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Human Vaccines & Immunotherapeutics |
spelling | doaj.art-b5aa70879ec84933a5de504c8c6e97a92023-09-22T08:45:34ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2020-06-011661313132110.1080/21645515.2019.16880321688032Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccinesPaolo Bonanni0Sara Boccalini1Angela Bechini2Ornella Varone3Giulio Matteo4Federica Sandri5Giovanni Gabutti6University of FlorenceUniversity of FlorenceUniversity of FlorenceUniversity of FlorenceUniversity of FerraraUniversity of FerraraUniversity of FerraraSimultaneous administration of different vaccines is a strategy to increase the possibility to receive vaccines at appropriate age, safely and effectively, reducing the number of sessions and allowing a more acceptable integration of new vaccines into National Immunization Programs (NIPs). Co-administration can be performed when there are specific indications in the Summary of Product Characteristics (SmPC) of the vaccines; but, in absence of these indications, the practice is possible if there are no specific contraindications nor scientific evidence to discourage simultaneous administration. The aim of this work is to review the safety and efficacy of co-administration of the tetravalent measles, mumps, rubella, and varicella (MMRV) and the meningococcal C (Men C) conjugate vaccines after 12 months of age. Several studies demonstrated that MMRV and Men C conjugate vaccines can be administered concomitantly without a negative impact on the safety and immunogenicity of either vaccines, inducing highly immunogenic responses.http://dx.doi.org/10.1080/21645515.2019.1688032co-administrationsafetyefficacymeningococcal c vaccinemeaslesmumpsrubellavaricella vaccine |
spellingShingle | Paolo Bonanni Sara Boccalini Angela Bechini Ornella Varone Giulio Matteo Federica Sandri Giovanni Gabutti Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines Human Vaccines & Immunotherapeutics co-administration safety efficacy meningococcal c vaccine measles mumps rubella varicella vaccine |
title | Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines |
title_full | Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines |
title_fullStr | Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines |
title_full_unstemmed | Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines |
title_short | Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines |
title_sort | co administration of vaccines a focus on tetravalent measles mumps rubella varicella mmrv and meningococcal c conjugate vaccines |
topic | co-administration safety efficacy meningococcal c vaccine measles mumps rubella varicella vaccine |
url | http://dx.doi.org/10.1080/21645515.2019.1688032 |
work_keys_str_mv | AT paolobonanni coadministrationofvaccinesafocusontetravalentmeaslesmumpsrubellavaricellammrvandmeningococcalcconjugatevaccines AT saraboccalini coadministrationofvaccinesafocusontetravalentmeaslesmumpsrubellavaricellammrvandmeningococcalcconjugatevaccines AT angelabechini coadministrationofvaccinesafocusontetravalentmeaslesmumpsrubellavaricellammrvandmeningococcalcconjugatevaccines AT ornellavarone coadministrationofvaccinesafocusontetravalentmeaslesmumpsrubellavaricellammrvandmeningococcalcconjugatevaccines AT giuliomatteo coadministrationofvaccinesafocusontetravalentmeaslesmumpsrubellavaricellammrvandmeningococcalcconjugatevaccines AT federicasandri coadministrationofvaccinesafocusontetravalentmeaslesmumpsrubellavaricellammrvandmeningococcalcconjugatevaccines AT giovannigabutti coadministrationofvaccinesafocusontetravalentmeaslesmumpsrubellavaricellammrvandmeningococcalcconjugatevaccines |